Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med

Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, USA.
Nature medicine (Impact Factor: 28.05). 05/2012; 18(6):883-91. DOI: 10.1038/nm.2753
Source: PubMed

ABSTRACT Tumor-derived exosomes are emerging mediators of tumorigenesis. We explored the function of melanoma-derived exosomes in the formation of primary tumors and metastases in mice and human subjects. Exosomes from highly metastatic melanomas increased the metastatic behavior of primary tumors by permanently 'educating' bone marrow progenitors through the receptor tyrosine kinase MET. Melanoma-derived exosomes also induced vascular leakiness at pre-metastatic sites and reprogrammed bone marrow progenitors toward a pro-vasculogenic phenotype that was positive for c-Kit, the receptor tyrosine kinase Tie2 and Met. Reducing Met expression in exosomes diminished the pro-metastatic behavior of bone marrow cells. Notably, MET expression was elevated in circulating CD45(-)C-KIT(low/+)TIE2(+) bone marrow progenitors from individuals with metastatic melanoma. RAB1A, RAB5B, RAB7 and RAB27A, regulators of membrane trafficking and exosome formation, were highly expressed in melanoma cells. Rab27A RNA interference decreased exosome production, preventing bone marrow education and reducing, tumor growth and metastasis. In addition, we identified an exosome-specific melanoma signature with prognostic and therapeutic potential comprised of TYRP2, VLA-4, HSP70, an HSP90 isoform and the MET oncoprotein. Our data show that exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis, has prognostic value and offers promise for new therapeutic directions in the metastatic process.

Download full-text


Available from: Jianda D Yuan, May 23, 2014
  • Source
    • "; EX, exosome; ICPL, isotopecoded protein label; MV, microvesicle; S1P, sphingosine-1- phosphate; RT, room temperature studied populations are generated through fundamentally different mechanisms of cellular vesiculation [2]: microvesicles (MVs) are formed through the outward blebbing of the plasma membrane, and exosomes (EXs) are derived from the inward budding of the plasma membrane in a process coordinated by the endosomal-sorting complex required for transport machinery [3]. MVs are between 0.1 and 1␮m in size and EXs are smaller (50—100 nm), but both have been shown to transport RNAs and proteins that are functionally exchanged between cells [4] [5]. Importantly, comparisons between EVs and their originating cells have shown that the incorporation of mRNAs, microRNAs, and proteins into these organelles appears to happen in a selective manner [6] [7] [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: ERBB2/HER2 amplification activates signaling cascades that lead to a tumor cell phenotype. However, despite its remarkable importance in oncology, the consequences of HER2 amplification over the extracellular vesicles (EVs) content have not yet been investigated. Here we isolated EVs secreted by HB4a, a mammary luminal epithelial cell-line and C5.2, its HER2-overexpressing clone. We isolated two EV-sets (20K and 100K) by ultracentrifugation and used electron microscopy and Nanoparticle Tracking Analysis for their morphological characterization. We employed GeLC-MS/MS combined with isotope-coded protein labeling to evaluate cell-derived proteins and LC-MS/MS/label-free spectral-counting to quantify the EVs-proteome. We found higher HER2 levels in both C5.2-derived EVs when compared with C5.2 cells, suggesting its preferential shuttling. Proteins capable of inducing malignant transformation are enriched in both C5.2 EV-subsets, including two HER2-related proteins involved in cell motility and invasion, cofilin and CD44. MetaCore™ analysis indicated an enrichment of cell-adhesion and cytoskeleton-remodeling pathways in C5.2-EVs, as well as proteins related to HER2 signaling, such as the sphingosine-1-phosphate (S1P) pathway. Together our data indicates that in terms of protein content, distinct vesicle sets reinforce and complement each other. Our results also suggest that HER2-upregulated proteins from EVs may be relevant for cellular malignancy and can be potential biomarkers for HER2(+) cancer patients. This article is protected by copyright. All rights reserved.
    Proteomics 06/2014; 14(12). DOI:10.1002/pmic.201300485 · 3.97 Impact Factor
  • Source
    • "In melanoma tumor cells, tumorderived exosomes could act as factors that promote metastatic niche formation by 'educating' bone marrowderived cells toward a pro-vasculogenic and pro-metastatic phenotype via upregulation of c-Met. A specific expression pattern of Ras-related (Rab) proteins was associated with exosome production in melanoma (Peinado et al. 2012, Somasundaram & Herlyn 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Thyroid cancer is one of the most rapidly increasing malignancies. The reasons for this increase is not completely known, but increases in the diagnosis of papillary thyroid microcarcinomas and follicular variant of papillary thyroid carcinomas along with the enhanced detection of well differentiated thyroid carcinomas are probably all contributing factors. Although most cases of well differentiated thyroid carcinomas are associated with an excellent prognosis, a small percentage of patients with well differentiated thyroid carcinomas as well as most patients with poorly differentiated and anaplastic thyroid carcinomas have recurrent and/or metastatic disease that is often fatal. The cancer stem cell model suggests that a small number of cells within a cancer, known as cancer stem-like cells, are responsible for resistance to chemotherapy and radiation therapy, as well as for recurrent and metastatic disease.. In this review we will focus on current studies about thyroid cancer stem-like cells, the processes of epithelial to mesenchymal transition, and mesenchymal to epithelial transition that provide plasticity to cancer stem-like cell growth in addition to the role of microRNAs in cancer stem cell development and regulation. Understanding the biology of cancer stem cells, epithelial to mesenchymal transition and the metastatic cascade should lead to the design of more rational targeted therapies for highly aggressive and fatal thyroid cancers.
    Endocrine Related Cancer 04/2014; 21(5). DOI:10.1530/ERC-14-0002 · 4.91 Impact Factor
  • Source
    • "Once in the cytosol, however, EV cargo molecules will face a crowded environment with distinct chemical properties compared with the extracellular milieu, including a low diffusion rate and high nuclease activity. So far, an in-depth mechanistic understanding of these fundamental, cell biological events lags far behind the spectacular and rewarding demonstrations of EV functional effects at the systemic level [77]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Extracellular vesicles (EVs), e.g. exosomes and microvesicles, emerge as new signaling organelles in the exchange of information between cells at the paracrine and systemic level. It is clear that these virus like particles carry complex biological information that can elicit a pleiotropic response in recipient cells with potential relevance in physiology as well as in cancer and other pathological conditions. Numerous studies convincingly show that the molecular composition of EVs closely reflects their cell or tissue of origin. Thus, the signaling status of donor cells, more specifically their endosomal compartments, may largely determine the biological output in recipient cells, a process that we then may conceptualize as vesicle mediated phene transfer. Whereas more conventional modes of cell-cell communication mostly depend on extracellular ligand concentration and cell-surface receptor availability, the magnitude of the EV signaling response relies on the capture and uptake by target cells, allowing release of the EV content. Numerous reports point at the intriguing possibility that, among thousands of mRNAs, miRNAs, and proteins, single EV constituents effectuate the biological response, e.g. stimulation of angiogenesis and cancer cell metastasis, in recipient cells; however, we find it conceivable that strategies targeted at general mechanisms of EV function should provide more rational avenues for therapeutic intervention directed at the EV system. Such strategies include manipulation of EV formation in the endolysosomal system, EV stability in the extracellular milieu, and EV entry into target cells. Here, we provide important insights into potential mechanisms of EV transport in mammalian cells and how these may be targeted.
    Seminars in Cancer Biology 04/2014; 28(1). DOI:10.1016/j.semcancer.2014.04.007 · 9.33 Impact Factor
Show more